Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EORTC CLTF 2021 | The benefits of combination approaches in CTCL

Jan P. Nicolay, MD, Ruprecht Karls University of Heidelberg, Mannheim, Germany, talks on the use of combination approaches in the treatment of cutaneous T-cell lymphoma (CTCL), describing how the targeting of multiple pathways involved in cell death can prevent cells from bypassing apoptosis. This interview took place at the EORTC Cutaneous Lymphoma Group 20-21 meeting in Marseille.